Union Heritage Capital’s Gilead Sciences GILD Stock Holding History

Union Heritage Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,047	Closed	-$227K	–	61
2025 Q3	$227K	Hold	2,047	–	–	0.07%	63
2025 Q2	$227K	Hold	2,047	–	–	0.08%	63
2025 Q1	$229K	Hold	2,047	–	–	0.09%	63
2024 Q4	$189K	Hold	2,047	–	–	0.07%	58
2024 Q3	$172K	Hold	2,047	–	–	0.06%	58
2024 Q2	$140K	Hold	2,047	–	–	0.06%	58
2024 Q1	$150K	Buy	+2,047	New	+$157K	0.06%	58
2022 Q1	–	Sell	-10,630	Closed	-$772K	–	55
2021 Q4	$772K	Hold	10,630	–	–	0.36%	55
2021 Q3	$743K	Hold	10,630	–	–	0.35%	55
2021 Q2	$731K	Hold	10,630	–	–	0.34%	57
2021 Q1	$687K	Buy	+10,630	New	+$685K	0.34%	57

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Union Heritage Capital's GILD Position: Q4 2025 in Review

Union Heritage Capital sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 2,047 shares — an estimated $227K sold.

Union Heritage Capital first reported a position in GILD in Q1 2021 and held it in 11 quarters. The position peaked at $772K in Q4 2021. 2,220 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

Union Heritage Capital reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
Union Heritage Capital sold 2,047 Gilead Sciences shares in Q4 2025, an estimated $227K.
Union Heritage Capital first reported a position in Gilead Sciences in Q1 2021 and held it in 11 quarters.
Union Heritage Capital's Gilead Sciences position peaked at $772K in Q4 2021.
2,220 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Union Heritage Capital's 13F filing for Q4 2025, filed 13 Feb 2026.